Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01577953
Recruitment Status : Completed
First Posted : April 16, 2012
Last Update Posted : April 29, 2014
Information provided by (Responsible Party):
Sterna Biologicals GmbH & Co. KG

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2012
  Actual Study Completion Date : August 2012